NCT03673501 2026-02-05INTRIGUEDeciphera Pharmaceuticals, LLCPhase 3 Active not recruiting453 enrolled 20 charts
NCT00265798 2025-08-20Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib MalateNational Cancer Institute (NCI)Phase 2 Active not recruiting38 enrolled 9 charts